MNKD CIK: 899460

MannKind Corporation

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.22
FY22:
0.23
FY23:
0.37
FY24:
0.27
FY25:
0.29
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.10
FY22:
0.06
FY23:
0.10
FY24:
0.13
FY25:
0.50
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.32
FY22:
0.30
FY23:
0.48
FY24:
0.39
FY25:
0.79

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.05
FY22:
0.07
FY23:
0.10
FY24:
0.08
FY25:
0.17
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.48
FY22:
0.48
FY23:
0.62
FY24:
0.39
FY25:
0.67
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.21
FY22:
−0.25
FY23:
−0.25
FY24:
−0.08
FY25:
−0.05
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.32
FY22:
0.30
FY23:
0.48
FY24:
0.39
FY25:
0.79

All amounts in billions USD Data source:SEC EDGAR